Companies: 10,795·Total market cap: $144.5T
FOXO Technologies Inc.

FOXO Technologies Inc.

FOXOOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$2999
P/E Ratio
52W High$0.80595
52W Low$0.0001

FOXO Technologies Inc. (FOXO) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

foxo · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for FOXO Technologies Inc. (FOXO) measures how much investors pay for each dollar of the company's trailing earnings. FOXO's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
EPS (TTM)
-$0.00
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · FOXO Technologies Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2020 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Healthcare Information Services · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
FOXO Technologies Inc.
FOXO Technologies Inc.You
FOXO
$0MN/A-$0.00
Aclarion, Inc.
Aclarion, Inc.
ACON
$2MN/A-$13.60
Akari Therapeutics, Plc
Akari Therapeutics, Plc
AKTX
$17MN/A-$822.15
Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc.
DRMA
$1MN/A-$8.16
MSP Recovery, Inc.
MSP Recovery, Inc.
MSPR
$0MN/A-$359.78
P3 Health Partners Inc.
P3 Health Partners Inc.
PIII
$40MN/A-$45.26
Revelation Biosciences, Inc.
Revelation Biosciences, Inc.
REVB
$4MN/A-$14.36

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 6 of 6 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.05
2024-12-31
FY2024
$-0.93
2023-12-31
FY2023
$-7.08
2022-12-31
FY2022
$-84.00
2021-12-31
FY2021
$-66.13
2020-12-31
FY2020
$-43.27

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for FOXO Technologies Inc. (FOXO) measures how much investors pay for each dollar of the company's trailing earnings. FOXO's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.00 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

FOXO pe ratio · 6 questions

FOXO's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.00 and TTM EPS of -$0.00. Data sourced from Financial Modeling Prep via FOXO's SEC 10-K and 10-Q filings.

FOXO PE ratioWhat is FOXO PE ratioCurrent PE ratio of FOXOFOXO PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · FOXO Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08